Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05812690
Other study ID # STH21833
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 29, 2022
Est. completion date November 30, 2023

Study information

Verified date April 2023
Source Sheffield Teaching Hospitals NHS Foundation Trust
Contact Helen D Rodd, BDS, PhD
Phone 0114 2717882
Email h.d.rodd@sheffield.ac.uk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Background/study aim: Molar incisor hypomineralisation (MIH) is a common disorder of tooth development. Affected teeth have weak enamel and adult molars often require extensive treatment or even extraction. A preliminary study, carried out in Sheffield Dental Hospital, discovered that 12% of MIH children also had congenitally missing adult teeth, presenting further challenges to treatment-planning. This novel finding stimulated discussion between international MIH experts; whilst some clinicians had observed this association, others had not. Therefore the primary aim of this international study is to determine the association between MIH and missing teeth in different populations. This has important clinical and biological relevance in understanding the presentation and management of MIH. Participants/research sites: This study will include 584 children with MIH and a comparison group of 584 children without MIH. Young dental patients, aged 7-16 years, who attend for a check-up or treatment at one of the 15 participating countries will be invited to take part. The UK sites are Sheffield, Newcastle and University College London Dental Hospitals and all children will be seen by specialists/consultants in paediatric dentistry to confirm their diagnosis of MIH. The main inclusion criteria is that children have a dental xray as part of their routine care. Data collection: Following a routine dental check-up we will grade the severity of the participants' MIH (if present) and record any other dental anomalies (e.g. abnormal tooth number, position or shape). We will also check the dental xray for other anomalies that cannot be seen from the clinical exam. We will analyse the prevalence of MIH and association with other dental anomalies to see if there are difference according to sex or ethnicity and compare our findings with the non-MIH group. We anticipate the study will take 18 months.


Description:

The primary objective is to compare the overall prevalence of congenitally missing teeth/hypodontia (excluding wisdom teeth) in children (7-16 years old) with and without MIH. Secondary research questions/objectives The secondary research objectives are to: 1. Compare the prevalence of developmentally missing teeth (hypodontia) in MIH children based on region, ethnicity and gender 2. Determine the clinical pattern (including symmetry), severity and treatment need of MIH in children (aged 7-16years) referred to specialist paediatric dentistry services across the world, according to gender and ethnic group/region 3. Compare the prevalence of other co-existing developmental dental anomalies between the two groups 4. Compare the prevalence of developing third permanent molars between the two groups What is the scientific justification for the research? Molar incisor hypomineralisation (MIH) is one of the most common disorders of tooth development seen in paediatric dentistry practice around the world. A recent meta-analysis of 99 studies, in 43 different countries, estimated the global prevalence of MIH to be 13.1% with significant variations seen between super-regions, regions and countries. A wide variety of other dental anomalies are also seen in childhood, broadly encompassing deviations in tooth number, morphology, structure, position and eruption. Prevalence data for all these different developmental disorders vary widely, depending on the anomaly in question, diagnostic approach and the target population . It is also important to note that the presence of one anomaly should always alert clinicians to the possibility of others, as numerous studies have demonstrated significant inter-relationships between certain anomaly types. Recently, a UK study explored, for the first time, the prevalence of dental anomalies in children diagnosed with MIH. Clinical and radiographic examination of 101 children aged 6-15 years found that, in total, 29% of patients had another dental anomaly in addition to MIH (Walshaw et al., 2020). There are established guidelines for the management of children with MIH. In some situations, the extraction of one or more first permanent molars is the preferred option, providing all other permanent teeth (and preferably third permanent molars/wisdom teeth) are present. Thus, the congenital absence of a second premolar in the same quadrant would have considerable impact on this decision and potentially compromises long-term outcomes. A controlled study, exploring any association between the presence of MIH and hypodontia, in addition to other dental anomalies, is clearly warranted to better inform patient management. The need for earlier radiographic examination and definitive treatment for hypomineralised first permanent molars would be paramount if such an association is confirmed by the proposed multi-centre international study. Design and methodology. This will be a cross-sectional study involving children with MIH and a comparison group of non MIH-affected children. Burden to research participants Research participants (MIH and comparison group) will not be required to attend any additional visits other than their scheduled check-up or treatment visit. However, their dental check up will take slightly longer than normal (around an extra 5 minutes) as we will be recording in more detail than usual the condition of their enamel (using a validated scoring system of MIH). They will have a dental xray taken as part of their 'routine care' so will not be exposed to unnecessary ionising radiation. They will also be invited to have clinical photographs of their teeth, which may not have been part of their 'routine care'. They will also be verbally asked two (validated) questions about how they rate their own oral health, which is not part of routine care. Study population Participants will be recruited from patients attending for treatment, a recall or new patient assessment, in the host centres. Written informed consent will be obtained for study participation from parents/guardians and children. The 'experimental ' group will be children aged 7-16 years referred to specialist paediatric dentistry services for the management of MIH in the following countries: 1. Nigeria 2. Australia-2 centres (both Melbourne) 3. Chile 4. Egypt 5. India 6. Jordan 7. Netherlands- 2 centres 8. New Zealand 9. Qatar 10. Singapore 11. South Sudan 12. United Kingdom- 3 centres (London, Newcastle, Sheffield) 13. United States of America 14. United Arab Emirates 15. Saudi Arabia A sample size of 1168 children (584 per group) was calculated. In order to achieve this sample size, each centre will aim to recruit 84 participants (42 patients per MIH group and 42 patients per control group). Examiner training and calibration Examiner training and calibration will be conducted on-line, using Microsoft Teams, using a set of ten clinical images and radiographs to ensure that there is acceptable intra-and inter-examiner agreement for key parameters under investigation as follows: - Use of a validated MIH index to record severity status for first permanent molars; - Clinical and radiographic diagnosis of all dental anomalies (abnormal tooth size, position and shape) - Presence/absence of developing third permanent molars (wisdom teeth) - Degree of taurodontism (this is an abnormal root canal shape) in lower first permanent molars using established criteria/index All clinicians involved in recording these parameters will have to reach acceptable levels of repeatability. Examination and data collection An electronic data collection 'form' will be developed and piloted prior to commencement of the main study. The following non-identifiable patient and clinical variables will be recorded prior to transfer to a shared electronic dataset using secure processes. Demographics - Age - Sex - Ethnicity - Primary dental diagnosis for both MIH and control participants. - Children's global assessment of their own oral health status Radiographic characteristics All participants must have a full panoral (dental) radiograph of good diagnostic quality, taken for 'routine care'. A record will be made of any abnormalities of tooth shape, number and position from the radiographic presentation. Assessment of taurodontism (abnormal root canal shape) For patients with mature apical development of their first permanent mandibular molars (10 years and over) an objective assessment of taurodontism will be carried out using digital measurements from panoral (dental) radiographs. This will be done according to established protocols; in brief, a diagnosis of taurodontism will be made if the crown/root ratio of the tooth is >1.1 (indicating that the crown pulp shape is abnormally elongated compared to the root length). Data entry and statistical analysis. Each unit will be responsible for anonymised electronic data entry for their participants and will send the complete data set securely to the principal investigators for data analysis. Simple descriptive analysis will be used to present the demographic, clinical and radiographic findings for the MIH and control groups. In addition, statistical tests will be applied to determine: - Any significant difference in the prevalence of dental anomalies (notably congenitally missing teeth) between children with and without a diagnosis of MIH and according to gender and ethnicity - Any significant difference in the prevalence/degree of taurodontism (abnormal root canal shape) between children with and without a diagnosis of MIH and according to gender and ethnicity - Any significant associations between the severity of MIH and presence of developing wisdom teeth, taurodontism and dental anomalies, according to gender and ethnicity


Recruitment information / eligibility

Status Recruiting
Enrollment 1168
Est. completion date November 30, 2023
Est. primary completion date November 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 7 Years to 16 Years
Eligibility Eligibility criteria Participants are children aged 7-16 years-old, with and without MIH, who meet the inclusion criteria, and attend for assessment or treatment in the participating clinics. To avoid bias, the comparison group will not be solely drawn from a pool of orthodontic patients or those primarily referred with a known diagnosis of dental anomalies Generic inclusion criteria - all participants (both MIH and comparison groups) - No significant medical history (ASA = 2), syndromic conditions, cleft lip and/or palate. - Have an existing (full) pan-oral radiograph at recruitment or subsequently undergoes one for routine diagnostic purposes. - Child able to accept detailed clinical examination, radiographs (and photographs). - Parents and child able to consent/assent to participate in the study and have sufficient level of literacy/understanding to complete written consent forms (with support if necessary). MIH-group specific inclusion criteria. - Children diagnosed with MIH by a specialist in paediatric dentistry according to validated diagnostic criteria (Ghanim et al., 2017, Ghanim et al., 2019) Comparison-group specific inclusion criteria - Children referred to the host centre for the management of any dental condition other than MIH. MIH-group specific exclusion criteria - Children with an enamel defect that is not typical of MIH. Comparison-group specific exclusion criteria - Children with an atypical pattern of dental caries/extraction in their first permanent molars such that a possible diagnosis of MIH could not be excluded (Ghanim et al., 2017, Ghanim et al., 2019).

Study Design


Intervention

Other:
This is a non intervention - observation only study
This is non intervention study

Locations

Country Name City State
United Kingdom Charles Clifford Dental Hospital Sheffield S Yorks

Sponsors (1)

Lead Sponsor Collaborator
Sheffield Teaching Hospitals NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

References & Publications (5)

Baccetti T. A controlled study of associated dental anomalies. Angle Orthod. 1998 Jun;68(3):267-74. doi: 10.1043/0003-3219(1998)0682.3.CO;2. — View Citation

Brook AH. Variables and criteria in prevalence studies of dental anomalies of number, form and size. Community Dent Oral Epidemiol. 1975 Nov;3(6):288-93. doi: 10.1111/j.1600-0528.1975.tb00326.x. — View Citation

Ghanim A, Silva MJ, Elfrink MEC, Lygidakis NA, Marino RJ, Weerheijm KL, Manton DJ. Molar incisor hypomineralisation (MIH) training manual for clinical field surveys and practice. Eur Arch Paediatr Dent. 2017 Aug;18(4):225-242. doi: 10.1007/s40368-017-0293-9. Epub 2017 Jul 18. — View Citation

Schwendicke F, Elhennawy K, Reda S, Bekes K, Manton DJ, Krois J. Global burden of molar incisor hypomineralization. J Dent. 2018 Jan;68:10-18. doi: 10.1016/j.jdent.2017.12.002. Epub 2017 Dec 6. Erratum In: J Dent. 2019 Jan;80:89-92. — View Citation

Walshaw EG, Noble F, Conville R, Anne Lawson J, Hasmun N, Rodd H. Molar incisor hypomineralisation and dental anomalies: A random or real association? Int J Paediatr Dent. 2020 May;30(3):342-348. doi: 10.1111/ipd.12601. Epub 2019 Dec 13. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of a dental anomaly in children with and without MIH Presence of any dental anomaly (number, shape, eruption disturbance) recruitment until July 2023
Secondary Characteristics associated with presence of a dental anomaly in children with MIH Secondary outcome measures for this study include the clinical and/or radiographic severity of MIH in relation to participants' gender, ethnicity/country and their global self-reported oral health, recruitment until July 2023
See also
  Status Clinical Trial Phase
Completed NCT05585112 - Articaine 4% Versus Lidocaine 2% for Local Anesthesia of MIH-affected Maxillary Molars Phase 1/Phase 2
Completed NCT05200884 - Local Anesthesia With Lidocaine or Articaine for Molars Affected by MIH Phase 1/Phase 2
Completed NCT02084433 - Comparison of Intraosseous Anaesthesia Using a Computerized System (QuickSleeper) to Conventional Anesthesia N/A